Advertisements


Why Shares Of Micro-Cap Biotech Akari Therapeutics Are Ripping Higher

The thinly traded, nano-cap biotech Akari Therapeutics PLC (NASDAQ: AKTX) gap-opened higher Wednesday morning, and shares were advancing strongly on above-average volume. read more.....»»

Category: blogSource: benzingaAug 14th, 2019

Why Shares Of Micro-Cap Oncology Biotech Oasmia Are Ripping Higher

Shares of the thinly traded micro-cap biotech OASMIA PHARMACE/ADR (NASDAQ: OASM) were advancing strongly Friday. read more.....»»

Category: blogSource: benzingaJul 5th, 2019

Obalon Ticks Higher Amid Patent Abstract For Intragastric Device

Shares of micro-cap Obalon Therapeutics (NASDAQ: OBLN) traded higher after traders circulated the U.S. read more.....»»

Category: blogSource: benzingaJun 25th, 2019

No Solace For Aldeyra As Late-Stage Study Of Lead Drug In Anterior Uveitis Fails

Shares of Aldeyra Therapeutics Inc (NASDAQ: ALDX), a thinly traded micro-cap biotech, plummeted Tuesday morning. read more.....»»

Category: blogSource: benzingaJun 25th, 2019

Akari"s Lead Candidate Found Safe, Effective In Treating Eye Inflammation

Shares of Akari Therapeutics PLC (NASDAQ: AKTX) — a thinly traded nano-cap biotech focusing on therapies for autoimmune and inflammatory diseases — were soaring Wednesday.  read more.....»»

Category: blogSource: benzingaJun 19th, 2019

Mid-Afternoon Market Update: Dow Rises Over 100 Points; Akari Therapeutics Shares Spike Higher

Toward the end of trading Tuesday, the Dow traded up 0.52 percent to 26649.46 while the NASDAQ gained 1.36 percent to 8,124.01. The S&P also rose, gaining 0.91 percent to 2,934.57. Leading and Lagging Sectors read more.....»»

Category: blogSource: benzingaApr 23rd, 2019

Microcap Biotech Akari Rallies On Coversin Trial Results

Akari Therapeutics PLC (NASDAQ: AKTX) shares were surging Tuesday, breaking above the $4 barrier for the first time in about a month. read more.....»»

Category: blogSource: benzingaApr 23rd, 2019

Why Seelos Therapeutics Shares Are Surging Out Of The Gate

Thinly traded nanocap biotech Seelos Therapeutics Inc (NASDAQ: SEEL) is trading sharply higher on over three times its average volume. read more.....»»

Category: blogSource: benzingaMar 29th, 2019

FDA Delays Selinexor Approval By 3 Months — So Why Is Karyopharm Ripping Higher?

Karyopharm Therapeutics Inc (NASDAQ: KPTI) shares, which suffered a setback in late February following the release of the FDA's briefing document and panel vote on its multiple myeloma treatment c Latest Ratings for KPTI.....»»

Category: blogSource: benzingaMar 15th, 2019

Why Thinly Traded Biotech Akari Is Jumping More Than 150%

Akari Therapeutics PLC (NASDAQ: AKTX) shares were surging by more than 150 percent Wednesday after reporting a positive meeting with the FDA.  read more.....»»

Category: blogSource: benzingaMar 13th, 2019

Mubadala Investment Takes Stake In AMD

Advanced Micro Devices (NASDAQ: AMD) shares are higher after a 13G filing from Mubadala Investment Company on Thursday, which showed a 4.9% stake in the company. read more.....»»

Category: blogSource: benzingaAug 16th, 2019

61 Biggest Movers From Yesterday

Gainers Akari Therapeutics PLC (NASDAQ: AKTX) shares jumped 61.3% to close at $2.92 on Wednesday after the company received FDA fast track designation for its Nomacopan that treats patients with pediatric HSCT-TMA. read more.....»»

Category: blogSource: benzingaAug 15th, 2019

Good News for Stem Cell Transplants

Akari Therapeutics shares jumped on Wednesday after the firm announced that the FDA has granted Fast Track designation for its stem cell transplant treatment......»»

Category: blogSource: 247wallstAug 14th, 2019

Akari Therapeutics" stock rockets on heavy volume after FDA grants nomacopan "Fast Track" designation

Shares of Akari Therapeutics PLC rocketed 61% to pace all premarket gainers in very active trading Wednesday, after the biopharmaceutical compan.....»»

Category: topSource: marketwatchAug 14th, 2019

Large Option Trader Sells TG Therapeutics Calls After Big Run

TG Therapeutics Inc (NASDAQ: TGTX) shares were trading higher for much of Monday's session before closing down 0.83%, and one large options trader was taking profits.   read more.....»»

Category: blogSource: benzingaAug 12th, 2019

Medison Expresses Concerns over Knight Therapeutics" Second Quarter Results and Demands Answers to Critical Questions from Jonathan Goodman

PETACH TIKVA, Israel, Aug. 9, 2019 /CNW/ - Medison Biotech (1995) Ltd. ("Medison"), which together with its affiliates owns more than 10.4 million shares or 7.5% of Knight Therapeutics, Inc. (TSX:GUD) ("Knight" or the "Company"), .....»»

Category: earningsSource: benzingaAug 9th, 2019

The Ratings Game: AMD stock surges after server chip Rome gives it ‘full control of the datacenter narrative’

Advanced Micro Devices Inc. shares are heading higher in premarket trading Thursday amid optimism for the company’s announcements about its second-generation Epyc 2 server chip, which is also called Rome......»»

Category: topSource: marketwatchAug 8th, 2019

Akari Therapeutics files to sell 136.18M ordinary shares for holders

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 6th, 2019

Sage Therapeutics Phase 3 data to drive shares higher, says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 6th, 2019

Mid-Day Market Update: Dow Down 170 Points; Gemphire Therapeutics Shares Spike Higher

Midway through trading Thursday, the Dow traded down 0.65% to 27,093.54 while the NASDAQ fell 0.95% to 8,242.83. The S&P.....»»

Category: earningsSource: benzingaJul 25th, 2019

NeuBase stock drops 15% in first day of trading

Pittsburgh’s newest public company lost 84 cents by the end of trading on Monday. Shares of NeuBase Therapeutics Inc. closed at $4.55 per share, down 15.58%. The biotech company was created through the reverse merger of NeuBase, a startup bas.....»»

Category: topSource: bizjournalsJul 16th, 2019